According to a preliminary WHO report published last month, naturally occurring CBD is safe and well tolerated in humans (and animals), and is not associated with any negative public health effects [PDF].
In acknowledgement of these kinds of discoveries in recent years, the report continued, ” Several countries have modified their national controls to accommodate CBD as a medicinal product.”
In this Monday, Nov. 6, 2017, photo, a syringe loaded with a dose of CBD oil is shown in a research . [+] laboratory at Colorado State University in Fort Collins, CO. (Credit: AP Photo/David Zalubowski)
In January 2019, WHO Director General Dr Tedros Ghebreyesus made a series of recommendations to the United Nations to update the scope of control of cannabis and cannabis-related substances. These new recommendations reflect the emerging therapeutic role of cannabis-based medicines whilst continuing to prevent diversion, misuse, and other public-health related harms that may arise from cannabis use.
This ECDD review on cannabis and cannabis-related substances was originally requested by Member States in 2009 through CND resolution 52/5 in 2009. The Committee then initiated the process in 2012 with a surveillance of cannabis during the 35 th , 37 th , and 38 th ECDD meetings. The decision for a formal review was recommended based on:
These recommendations are the outcome of a multi-year review process conducted by the Expert Committee on Drug Dependence (ECDD), an independent scientific advisory body to the WHO. Based on scientific assessment, potential health risk and therapeutic benefit, the ECDD recommends the appropriate scheduling of psychoactive substances within the international drug conventions. The review process leading up to these recommendations may start with a surveillance phase to monitor the risk and therapeutic use and to assess the available data in order to discern whether a full review is necessary and confirm that evidenced-based recommendations are possible. A subsequent pre-review allows for an initial in-depth assessment, which may be followed by a critical review in order to make scheduling recommendations.